Atlas Venture Fund XII, L.P. - 10%+ Owner at Jade Biosciences, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
JBIO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Atlas Venture Fund XII, L.P. since 21 Oct 2025

Reported holdings for Atlas Venture Fund XII, L.P. in Jade Biosciences, Inc.

Form 4 holding 10%+ Owner

Aerovate Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,327,909
Estimated value
$45,394,226
Report date
15 Jul 2022
Price
$19.50
Ownership
Direct

Transaction history for Atlas Venture Fund XII, L.P. in Jade Biosciences, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .